AngioDynamics Long Term Debt to Equity Trend from 2010 to 2023

ANGO Stock  USD 13.45  0.09  0.67%   
AngioDynamics Long Term Debt to Equity yearly trend continues to be quite stable with very little volatility. Long Term Debt to Equity may rise above 0.07 this year. From the period between 2010 and 2023, AngioDynamics, Long Term Debt to Equity regression line of its data series had standard deviation of 0.09 and standard deviation of  0.09. AngioDynamics Interest Expense is quite stable at the moment as compared to the past year. The company's current value of Interest Expense is estimated at 635,495. Operating Expenses is expected to rise to about 224.5 M this year, although the value of Direct Expenses will most likely fall to about 130.8 M.
  
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics main balance sheet or income statement drivers, such as Direct Expenses of 130.8 M, Cost of Revenue of 131.1 M or Gross Profit of 145.1 M, as well as many exotic indicators such as Interest Coverage of 2.76, Long Term Debt to Equity of 0.0695 or PPandE Turnover of 6.82. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules. It can also supplement AngioDynamics' financial leverage analysis and stock options assessment as well as various AngioDynamics Technical models . Please continue to the analysis of AngioDynamics Correlation against competitors.

AngioDynamics Long Term Debt to Equity Breakdown

Showing smoothed Long Term Debt to Equity of AngioDynamics with missing and latest data points interpolated. AngioDynamics' Long Term Debt to Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt to Equity10 Years Trend
Down
Slightly volatile
   Long Term Debt to Equity   
       Timeline  

AngioDynamics Long Term Debt to Equity Regression Statistics

Arithmetic Mean0.14
Geometric Mean0.11
Coefficient Of Variation58.93
Mean Deviation0.07
Median0.17
Standard Deviation0.09
Sample Variance0.007282
Range0.26
R-Value(0.54)
Mean Square Error0.005614
R-Squared0.29
Significance0.04768
Slope(0.010955)
Total Sum of Squares0.09

AngioDynamics Long Term Debt to Equity History

2013 0.17
2014 0.24
2015 0.21
2016 0.18
2017 0.16
2018 0.2
2019 0.0879
2020 0.0455
2021 0.0589
2022 0.0677
2023 0.0695

About AngioDynamics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AngioDynamics income statement, its balance sheet, and the statement of cash flows. AngioDynamics investors use historical funamental indicators, such as AngioDynamics's Long Term Debt to Equity, to determine how well the company is positioned to perform in the future. Although AngioDynamics investors may use each financial statement separately, they are all related. The changes in AngioDynamics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AngioDynamics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AngioDynamics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AngioDynamics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Long Term Debt to Equity 0.07  0.07 
Average Equity387.6 M420.3 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in AngioDynamics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving against AngioDynamics

-0.6MSFTMicrosoft Aggressive PushPairCorr
-0.59AXSMAxsome Therapeutics Sell-off TrendPairCorr
-0.51INCYIncyte Earnings Call This WeekPairCorr
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of AngioDynamics Correlation against competitors. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEO Directory
Screen CEOs from public companies around the world
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
522.8 M
Quarterly Revenue Growth
0.091
Return On Assets
(0.0247) 
Return On Equity
(0.08) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.